US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 11.990
  • -0.370-2.99%
Close Mar 25 16:00 ET
  • 11.400
  • -0.590-4.92%
Pre 04:06 ET
448.91MMarket Cap-31.55P/E (TTM)

Oruka Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oruka Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--------

Unlock Free Earnings Estimates

Oruka Therapeutics Earnings Reports

  • 10-K: Annual report

    Mar 6 16:02 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:08 ET

  • 8-K: Current report

    Aug 1, 2024 16:27 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 16:08 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Enerpac Tool
    EPAC
    +8.39%
    Precision Drilling
    PDS
    +2.04%
    Halozyme Therapeutics
    HALO
    +1.28%
    Workday
    WDAY
    +1.17%
    Lantheus
    LNTH
    +0.33%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 13, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data